Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme

BACKGROUND: As the most aggressive brain tumor, patients with glioblastoma multiforme (GBM) have a poor prognosis. Our purpose was to explore prognostic value of Polo-like kinase 2 (PLK2) in GBM, a member of the PLKs family. METHODS: The expression profile of PLK2 in GBM was obtained from The Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Xiangping, Cao, Fang, Yuan, Xiaolu, Zhang, Qiang, Chen, Wei, Yu, Yunhu, Xiao, Hua, Han, Chong, Yao, Shengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873877/
https://www.ncbi.nlm.nih.gov/pubmed/31763067
http://dx.doi.org/10.7717/peerj.7974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873877/
https://www.ncbi.nlm.nih.gov/pubmed/31763067
http://dx.doi.org/10.7717/peerj.7974

Ejemplares similares